From Name:
From Email:
To Name:
To Email:

Optional Message:

Wave of interest in new cancer therapy

from Medical Press

The Director of Biotechnology at Victoria University is part of a multidisciplinary team that aims to use viruses and bacteria, or microbes, that cause diseases, such as measles, botulism, gangrene and the common cold, as the basis of new forms of cancer treatment. These microbes will be engineered to make an enzyme that can activate cancer prodrugs — a new generation of therapies that remain inert in the body until activated by the enzymes that Dr Ackerley's group at Victoria are developing. There is growing international interest in prodrugs as an alternative to chemotherapy, because of their ability to kill cancer cells while leaving healthy cells unharmed. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063